The founder of a company acquired for $13.5 million has sued GoodRx, saying he's still owed a seven-figure equity payout.
StockStory.org on MSN
GoodRx (GDRX) stock trades up, here is why
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 2.6% in the afternoon session after the company ...
GoodRx launched a $14.99 monthly subscription for discounts on medications, telehealth and routine lab services.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...
Zacks Investment Research on MSN
GoodRx (GDRX) upgraded to buy: What does it mean for the stock?
GoodRx Holdings, Inc. (GDRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Americans spend more than $420 billion per year at pharmacies for prescription drugs, according to a 2022 report from the Department of Health and Human Services. Prescription discount cards help ...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results ...
Save money on prescriptions and find healthcare resources from a trusted source. There’s no prescription for peace of mind. But you can find it with a click using GoodRx. Since 2011, the healthcare ...
GoodRx Holdings, Inc. faces ongoing revenue and margin pressure as its legacy business declines and Pharma Direct grows but with lower profitability. GDRX’s Q1 results showed a 4% Y/Y revenue drop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results